A single booster dose is now authorized for those who received Pfizer’s COVID-19 vaccine for doses 1 and 2. This authorization came after review by VRBPAC, FDA, ACIP, and CDC. Read the FDA’s emergency use authorization (EUA) for more information.
Populations Eligible for a Booster Dose of Pfizer’s COVID-19 Vaccine:
- People 65 years and older should receive a booster shot at least 6 months after their primary series
- Residents in long-term care settings should receive a booster shot at least 6 months after their primary series
- People aged 50–64 years with underlying medical conditions that increase their risk of severe COVID infection should receive a booster shot at least 6 months after their primary series
- People aged 18–49 years with underlying medical conditions that increase their risk of severe COVID infection may receive a booster shot at least 6 months after their primary series, based on their individual benefits and risks
- People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot at least 6 months after their primary series, based on their individual benefits and risks
Other Important Considerations:
- “Primary series” refers to a person who has 2 doses of Pfizer’s vaccine, 2 doses of Moderna’s vaccine, or 1 dose of Johnson & Johnson’s vaccine. However, see the following exceptions:
- This booster recommendation does not apply to those that received Moderna’s COVID-19 vaccine or Johnson & Johnson’s COVID-19 vaccine for their primary series. Recommendations for those who received Moderna and Johnson & Johnson vaccines are forthcoming, based upon available data.
- These recommendations for a booster dose do not apply to a person who is immunocompromised and may need an additional dose. Information on guidance for immunocompromised individuals is at the bottom of this Special Alert.
- The definition of “fully vaccinated” has not changed. Fully vaccinated refers to a person who has 2 doses of Pfizer’s vaccine, 2 doses of Moderna’s vaccine, or 1 dose of Johnson & Johnson’s vaccine
We are waiting for guidance from DHS for more specific eligibility criteria. Please continue to monitor our website for more information.
Thanks for choosing IPACK Pharmacy to be your COVID-19 vaccine provider. Being the Milwaukee centered local independent pharmacy, we are proud to serve the community.
Please choose a date and follow the instructions to book your appointment for the COVID-19 vaccine.
For parents/guardians reserving appointments for 12-15 years old, we will begin vaccinating 12 years of age and older beginning May13th, per DHS announcement on May 12th. All 12-15 year olds will need to be accompanied by a parent/guardian.
Per state guidance anyone over 12 years of age is eligible to receive the vaccine, however anyone under 18 year old should be accompanied by a parent/guardian.
Be sure to bring your state issued ID/drivers license and your **prescription** insurance card. Please make sure “RxBIN, RxPCN, RxGrp” are on the card, otherwise it is likely to be your medical card that cannot be used in the pharmacy. If you do not have insurance, you will still receive your vaccine as long as you are eligible, more info will be collected for the governmental funding to cover for you at the appointment.
If you are over the age of 65, or who is eligible for the Medicare, please bring your Medicare Part A/B card. This is the Federal issued red, white and blue card. All medicare beneficiaries have one. If you are under “Medicare Advantage” and was told there is no Medicare card, please call 1-800-Medicare (1-800-633-4227) to request a new card, ask for your “MBI” (Medicare Beneficiary Identifier), and bring your MBI to the appointment.